JULIE SCHULTZ: Open Payments
NPI 1982485207 · WINCHESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,546 in 145 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $2,683 · 2025 $3,546
Food & beverage: $3,374Education: $173
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $596 |
| UCB, Inc. | 16 | $556 |
| GENZYME CORPORATION | 13 | $429 |
| Arcutis Biotherapeutics, Inc. | 10 | $309 |
| Organon LLC | 12 | $242 |
| Galderma Laboratories, L.P. | 15 | $220 |
| Regeneron Healthcare Solutions, Inc. | 10 | $205 |
| Amgen Inc. | 8 | $204 |
| Lilly USA, LLC | 10 | $152 |
| ABBVIE INC. | 16 | $144 |
Products named: DUPIXENT, TREMFYA, Bimzelx, Zoryve, OTEZLA, NEMLUVIO, SKYRIZI, OPZELURA.
Industry payments across MA — which companies pay providers there.
